Sleep Loss and Substance Use Disorders: An Issue from Adolescents to Adults

Area of Science:

• Neuroscience
• Public Health
• Adolescent Medicine

Background:

• Insomnia and sleep disturbances are prevalent worldwide, affecting both general populations and adolescents.
• A concerning bidirectional relationship exists between sleep disturbances and the risk of developing substance use disorders (SUDs).
• Global substance consumption, particularly alcohol, nicotine, and cannabis, is increasing, with a notable rise in adolescent onset.

Purpose of the Study:

• To explore the link between unsatisfactory sleep and the heightened risk of substance use disorder development.
• To investigate the potential role of the orexinergic system in the sleep disturbance-SUD association.
• To identify adolescence as a critical period for establishing maladaptive loops that may predispose individuals to SUDs.

Main Methods:

• Review of existing literature on sleep disturbances, substance use, and the orexinergic system.
• Analysis of studies examining the effects of orexinergic antagonists on insomnia symptoms.
• Examination of postmortem studies on orexin neuron activity in individuals with a history of substance use.

Main Results:

• Evidence suggests a connection between sleep problems and increased susceptibility to substance use disorders.
• Orexinergic system dysregulation is implicated, as orexin antagonists show promise in treating insomnia.
• Postmortem studies reveal elevated orexin immunoreactive neurons in habitual opioid users, suggesting a role for this system.

Conclusions:

• Adolescence may be a critical developmental window where the interplay between poor sleep and the orexinergic system can initiate a pathway toward substance use disorders.
• Targeting the orexinergic system could offer potential therapeutic avenues for both sleep disturbances and SUD prevention/treatment.
• Understanding this link is crucial for public health strategies aimed at mitigating the rising rates of adolescent substance use.